1833.HK
Legend Biotech is a biotech

Ping An Healthcare and Technology Co. Ltd. (1833.HK) on Wednesday reported its revenue rose 2.9% last year to 4.81 billion yuan ($665 million), as it ended years of losses to record its first net profit of 81.42 million yuan for the year. Revenue from its integrated financial clients rose 9.6% to 2.42 billion yuan, while the contribution from its corporate clients rose 32.7% to 1.43 billion yuan. 

The company attributed its move into the black to improved operational efficiency, AI-driven initiatives and enhanced production and investment controls. It said it has achieved economies of scale from its gradual business expansion. The company said it integrated DeepSeek with its large multi-modal Ping An Medical Master and Ping An Doctor’s Home apps, and completed validation and application under some scenarios.

Shares of Ping An Healthcare opened up 1.13% at HK$8.04 on Thursday. But the shares are down over 55% from their peak during the past six months.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Refire makes hydrogen fuel cells

Refire strings along investors with hydrogen hype

The maker of hydrogen fuel cell systems reported its revenue continued to contract in the first half of 2025, though at a lower rate than last year Key Takeaways: Shanghai…